Gregory Katz

Grégory Katz-Bénichou (1971) is a French academic and executive manager. He is currently head of research and innovation at the hospital group ESLAN. Until 2015, he was head of innovation and research at Ramsay - Générale de Santé, and director of its not-for-profit Foundation. In parallel, Gregory Katz was professor at ESSEC Business School (Paris-Singapore). Between 2003 and 2015, he was chaired professor of the ESSEC Chair of Therapeutic Innovation, and co-director of the ESSEC Institute of Health Economics & Management. In 2009 he won the San Benedetto International Award for his work on bioethics and humanism. Recognized as a Leading Scholar 2015 by the UCLA Fielding School of Public Health, he was guest of honor at the Public Health Grand Rounds Lecture 2015 at the University of California in Los Angeles (UCLA).

Born in Paris in 1971, Gregory Katz holds a Master of Business Administration (ESSEC, 1997), a doctorate in philosophy (Université de Paris-Sorbonne, 2000) and a doctorate in pharmacy (Université de Paris-Descartes, 1999). Elie Wiesel, professor at Boston University and Nobel Peace Prize laureate mentored his doctorate in philosophy at the Université de Paris-Sorbonne.

In 2003, Gergory Katz became a permanent faculty member atESSECBusiness School (Paris-Singapore). In 2004, he was appointed chaired professor of the ESSEC Chair of Therapeutic Innovation, which he created that same year. As visiting professor at INSEAD in 2004-2005 on the Singapore campus, he taught business ethics alongside Henri-Claude de Bettignies at the Asian Center for Comparative Management. In 2006, Katz was a visiting professor at Bocconi University (Milan) at the Center for Research on Health Care and Social Management. In 2009 he was named co-director of the ESSEC Institute of Health Economics & Management. From 2011 to 2013, he was Academic Director of the Executive Master Strategy & Management of Health Industries at ESSEC Executive Education.

In 2004, Gregory Katz was elected vice-president of the association Eurocord. From 2009 to 2012, he was administrator of the European School of Surgery.20 From 2012 to 2014, he was a member of the first expert panel of the French Institutional Review Board (CPP IDF3).35 From 2012 to 2015 he was Pro Bono Chairman of the Board of GlaxoSmithKlineVaccines’ Global Innovation Fund.[23]Since 2015, Gregory Katz has been a member of the advisory board of the doctoral school of life sciences and health at University Paris-Est.

...
Wikipedia